Theravance Biopharma TBPH
NASDAQ TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Divestments (2020)

Updated

Theravance Biopharma's Divestments came in at $2.71 million for FY2022.

Analysis

Theravance Biopharma (TBPH) Divestments (2020) Analysis & Trends

  • Divestments carries a four-year compound annual growth rate of -39.3% (FY2018 to FY2022).
  • The FY2022 figure represents the highest annual Divestments since FY2019.
  • Per Business Quant, earlier years put Divestments at $5 million in FY2019 (-75.0%) and $20 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 87.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 1.88 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Theravance Biopharma 883.70 Mn -543.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 14.93 Mn
API Access

Theravance Biopharma Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=TBPH&period=max&api_key=YOUR_API_KEY